The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis

Overview of attention for article published in Multidisciplinary Respiratory Medicine, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 8 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

INHALABLE PHARMACEUTICAL COMPOSITION COMPRISING THE PROTEIN ANAKINRA FOR THE TREATMENT OF…

Application WO-2023203586-A1

World Intellectual Property Organisation (WIPO)

USE OF ESCULENTIN AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS

Application WO-2021074025-A1

World Intellectual Property Organisation (WIPO)

USO DI ESCULENTINA E SUOI DERIVATI PER USO PER IL TRATTAMENTO DELLA FIBROSI CISTICA

Application IT-201900018938-A1

Italy

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.